RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL
· Real-Time Price · USD
1.37
-0.02 (-1.44%)
At close: Aug 15, 2025, 3:59 PM
1.39
1.36%
After-hours: Aug 15, 2025, 06:45 PM EDT
RedHill Biopharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.59M | -2.59M | -1.54M | -1.54M | -13.54M | -13.54M | 761K | 50.24M | -3.73M | -35.7M | -11.71M | -17.14M | -24.37M | -21.39M | -29.12M | -22.86M |
Depreciation & Amortization | 100.5K | 100.5K | 209K | 209K | 202.5K | 202.5K | -58.9M | 60.48M | 2.01M | 2.09M | 1.92M | 2.14M | 11.19M | 2.34M | 2.29M | 2.32M |
Stock-Based Compensation | 218K | 218K | 114.5K | 114.5K | 399K | 399K | 705K | 144K | 1.14M | 1.61M | 618K | 2.31M | 1.88M | 2.19M | 5.27M | 872K |
Other Working Capital | 1.16M | 1.16M | 529K | 529K | -4.14M | -4.14M | 1.25M | -30.2M | 1.74M | 3.05M | 1.22M | 5.09M | 2.69M | -705K | 935K | 7.13M |
Other Non-Cash Items | 228K | 228K | -3.5M | -3.5M | 7.63M | 7.63M | 46.21M | -120.81M | -6.08M | 25.63M | -2.02M | 3.12M | 678K | 886K | 1.23M | 2.69M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4K | 37K | 17K | 17K | 52K |
Change in Working Capital | 451.5K | 451.5K | 1.63M | 1.63M | -3.71M | -3.71M | 638K | 2.76M | 4.24M | 342K | -5.38M | 5.41M | -4.23M | -3.06M | 1.42M | 4.71M |
Operating Cash Flow | -1.59M | -1.59M | -3.09M | -3.09M | -9.02M | -9.02M | -10.59M | -7.19M | -2.42M | -6.03M | -16.58M | -4.16M | -14.86M | -19.02M | -18.9M | -12.27M |
Capital Expenditures | -4K | -4K | -500 | -500 | -2K | -2K | -7K | n/a | -1.34K | -22K | -163K | -13K | -3K | -21K | -3K | -88K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.5M | -8.5M | -3.5M | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8.5M | -55.67K | -53.4K | 8.5M | 814.34 | 1.09K | 3.34K | 475K |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 7.5K | 7.5K | n/a | n/a | 1.34K | 55.67K | 53.4K | 8.5M | 3.5M | -8.5M | -3.5M | 475K |
Investing Cash Flow | -4K | -4K | -500 | -500 | 5.5K | 5.5K | -7K | n/a | -8.5M | -22K | -163K | 8.49M | 3.5M | -8.52M | -3.5M | 387K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | -293K | -296K | -384K | -621K | -355K | -115K | -454K | -442K | -402K | -383K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 258.5K | 258.5K | 3.95M | 3.95M | 8.31M | 8.31M | 1.91M | -1.6M | n/a | -4.99M | -236K | -5.54M | -1.8M | -1.06M | -1.64M | 1.1M |
Financial Cash Flow | 258.5K | 258.5K | 3.95M | 3.95M | 8.31M | 8.31M | 3K | 4.81M | 7.2M | -5.72M | 14.92M | -4.94M | 17.57M | -999K | -1.77M | 58.66M |
Net Cash Flow | n/a | n/a | n/a | n/a | n/a | -7M | -10.57M | -2.4M | 4.76M | -11.78M | -1.86M | -627K | 6.22M | -28.56M | -24.16M | 46.68M |
Free Cash Flow | -1.6M | -1.6M | -3.09M | -3.09M | -9.02M | -9.02M | -10.6M | -7.19M | -2.42M | -6.05M | -16.74M | -4.17M | -14.86M | -19.05M | -18.9M | -12.36M |